Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors
نویسندگان
چکیده
Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped single-stranded positive-sense RNA virus, is a member of the genus Betacoronavirus , family Coronaviridae. The SARS-CoV envelope protein E small (?8.4 kDa) channel-forming membrane whose sequence highly conserved between and SARS-CoV-2. As viroporin, it involved in various aspects virus life cycle including assembly, budding, formation, release, inflammasome activation. Here, was recombinantly expressed HEK293 cells channel activity effects viroporin inhibitors studied using patch-clamp electrophysiology cell viability assay. We introduced membrane-directing signal peptide to ensure transfer recombinant plasma membrane. expression induced transmembrane currents that were blocked by inhibitors. In ion-reduced buffer system, proton-dependent rimantadine amantadine. I-V relationships not pH-dependent classical system with high extracellular Na + intracellular K . E-protein mediated inhibited amantadine rimantadine, as well 5-(N,N-hexamethylene)amiloride (HMA). tested total 10 flavonoids, finding inhibitory varying potency. Epigallocatechin quercetin most effective, IC 50 values 1.5 ± 0.1 3.7 0.2 nM, respectively, similar potency (IC = 1.7 0.6 nM). Patch-clamp results independently verified modified assay for These contribute development novel antiviral drugs suppress proliferation.
منابع مشابه
Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay.
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide. Although a number of promising potential vaccines and therapeutic agents for SARS-CoV have been described, no effective antiviral drug against SARS-CoV is currently available. The intricate, sequential nature of the viral entr...
متن کاملEvaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
Compounds approved for therapeutic use and in vitro inhibitors of severe acute respiratory syndrome coronavirus (SARS-CoV) were evaluated for inhibition in the mouse SARS-CoV replication model. A hybrid interferon, interferon alpha (IFN-alpha) B/D, and a mismatched double-stranded (ds) RNA interferon (IFN) inducer, Ampligen (poly I:poly C124), were the only compounds that potently inhibited vir...
متن کاملYeast Based Small Molecule Screen for Inhibitors of SARS-CoV
Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is high. The SARS-CoV papain-like protease (PLP) is an attractive target for pharmaceutical development because it is essential for virus replication ...
متن کاملAntimyogenic Effect of SARS-CoV Spike Protein in C2C12 Myoblasts
C2C12 myoblasts serve as well-established model system to study myogenesis, as they fuse to form multinucleated myotubes. Severe acute respiratory syndrome coronavirus (SARS–CoV) spike (S) protein plays a crucial role in viral entry. Exogenous expression of S protein in C2C12 myoblasts inhibits the formation of myotubes. Global changes in gene expression were studied in C2C12 cells expressing S...
متن کاملSevere acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
The coronavirus SARS-CoV is the primary cause of the life-threatening severe acute respiratory syndrome (SARS). With the aim of developing therapeutic agents, we have tested peptides derived from the membrane-proximal (HR2) and membrane-distal (HR1) heptad repeat region of the spike protein as inhibitors of SARS-CoV infection of Vero cells. It appeared that HR2 peptides, but not HR1 peptides, w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Microbiology
سال: 2021
ISSN: ['1664-302X']
DOI: https://doi.org/10.3389/fmicb.2021.692423